PeptideDB

NEO 376 496921-73-4

NEO 376 496921-73-4

CAS No.: 496921-73-4

NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator that may be utilized in the researc
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator that may be utilized in the research/study of psychosis.

Physicochemical Properties


Molecular Formula C20H24N3OCL
Molecular Weight 357.87706
Exact Mass 357.16
CAS # 496921-73-4
PubChem CID 9906770
Appearance White to off-white solid powder
Density 1.3±0.1 g/cm3
Boiling Point 547.7±50.0 °C at 760 mmHg
Flash Point 285.1±30.1 °C
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.649
LogP 4.3
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 4
Heavy Atom Count 25
Complexity 466
Defined Atom Stereocenter Count 0
SMILES

O=C1C2=C(N(CCN3CCN(C4=CC=CC(Cl)=C4)CC3)C=C2)CCC1

InChi Key CQSQHUPRBBCQRE-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H24ClN3O/c21-16-3-1-4-17(15-16)23-12-9-22(10-13-23)11-14-24-8-7-18-19(24)5-2-6-20(18)25/h1,3-4,7-8,15H,2,5-6,9-14H2
Chemical Name

1-[2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl]-6,7-dihydro-5H-indol-4-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity



Solubility Data


Solubility (In Vitro) DMSO : ~125 mg/mL (~349.28 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (5.81 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (5.81 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (5.81 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.7942 mL 13.9712 mL 27.9423 mL
5 mM 0.5588 mL 2.7942 mL 5.5885 mL
10 mM 0.2794 mL 1.3971 mL 2.7942 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.